FDA
-
-
-
-
-
-
-
Mereo BipPharma Group (MREO) PT Lowered to $1 at BTIG
-
-
-
-
-
-
-
Mereo BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Highlights
-
-
-
-
-
-
-
Mereo BioPharma Provides Update on Lead Clinical Programs
-
-
-
-
-
-
-
Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market
-
-
-
-
-
-
-
Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
BTIG Assumes Mereo BipPharma Group (MREO) at Buy
-
-
-
-
-
-
-
Mereo BioPharma to Present at the Jefferies Healthcare Conference
-
323,573 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

